Results 141 to 150 of about 69,242 (204)

The landscape of ADAMTS13-related tests in thrombotic thrombocytopenic purpura: a review. [PDF]

Front Med (Lausanne)
Meng C, Halkidis K.
europepmc   +1 more source

Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors. [PDF]

Res Pract Thromb Haemost
Story CM, Brown J, Martin C, Chaturvedi S.   +3 more
europepmc   +1 more source

Pathological Allostery in ADAMTS13: Autoantibody-Induced Modulation and Its Role in Immune Thrombotic Thrombocytopenic Purpura (iTTP). [PDF]

Pharmaceuticals (Basel)
Gil M, Halkidis K.
europepmc   +1 more source

Regarding "Challenges in diagnosing thrombotic thrombocytopenic purpura". [PDF]

Hematol Transfus Cell Ther
Martins de Oliveira Filho C, Carney BJ.
europepmc   +1 more source

Acute large vessel occlusion stroke as a neurovascular complication of immune thrombotic thrombocytopenic purpura: Mechanical thrombectomy and neurocritical care challenges. [PDF]

Surg Neurol Int
Ombada M, Ombada MSA, Omar K.
europepmc   +1 more source

Human monoclonal and polyclonal anti-ADAMTS13 antibodies in immune thrombotic thrombocytopenic purpura: variable mechanisms of inhibition. [PDF]

J Thromb Haemost
Meng C, Halkidis K, Gil M, Liu S, Zheng XL.   +4 more
europepmc   +1 more source

The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study. [PDF]

Front Pharmacol
Markovic U, Sapuppo G, Frazzetto S, Grasso S, Duminuco A, Giunta G, Calagna M, Esposito B, Fazio M, Nardo A, Gullo L, Santuccio G, Sorbello CMC, Leotta D, La Penta S, Di Raimondo F, Giuffrida G.   +16 more
europepmc   +1 more source

[Treatment of thrombotic thrombocytopenic purpura].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2014
openaire   +2 more sources

The modern role of corticosteroids in immune thrombotic thrombocytopenic purpura. [PDF]

Ann Blood
Halkidis K.
europepmc   +1 more source